Jci_page_head_homepage_01 Jci_page_head_homepage_02
Ja-Young Kim, Esther van de Wall, Mathieu Laplante, Anthony Azzara, Maria E. Trujillo, Susanna M. Hofmann, Todd Schraw, Jorge L. Durand, Hua Li, Guangyu Li, Linda A. Jelicks, Mark F. Mehler, David Y. Hui, Yves Deshaies, Gerald I. Shulman, Gary J. Schwartz, Philipp E. Scherer
Published in Volume 117, Issue 9
J Clin Invest. 2007; 117(9):2621–2637 doi:10.1172/JCI31021
Abstract | Full text | PDF
Options: View larger image (or click on image)
Medium
Figure 1
ob/ob mice overexpressing adiponectin display physiological overexpression of adiponectin in circulation with normal adiponectin complex distribution.

(A) Circulating adiponectin levels were measured by RIA in 12-week-old adiponectin transgenic ob/ob mice (Ad Tg ob/ob), their ob/ob littermates, and ob/ob mice with PPARγ agonist treatment (n = 5 mice/group). (B) Tissue levels of adiponectin were measured in various fat pads, determined by Western blot analysis, and normalized with GDI in 12-week-old male adiponectin transgenic ob/ob mice, their ob/ob littermates, and ob/ob mice with PPARγ agonist treatment (n = 5 mice/group). (C) The complex distribution of adiponectin of female mice was determined using gel filtration chromatography of serum samples followed by Western blot analysis of adiponectin in different fractions. A representative sample is shown. HMW, high molecular weight form; LMW, low molecular weight form (hexamer). *P < 0.05; **P < 0.01 by Student’s t test.